p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 08 08 2020
accepted: 11 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 6 11 2021
Statut: epublish

Résumé

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) that exist on a spectrum of neurodegenerative disease. A hallmark of pathology is cytoplasmic TDP-43 aggregates within neurons, observed in 97% of ALS cases and ~ 50% of FTLD cases. This mislocalisation from the nucleus into the cytoplasm and TDP-43 cleavage are associated with pathology, however, the drivers of these changes are unknown. p62 is invariably also present within these aggregates. We show that p62 overexpression causes TDP-43 mislocalisation into cytoplasmic aggregates, and aberrant TDP-43 cleavage that was dependent on both the PB1 and ubiquitin-associated (UBA) domains of p62. We further show that p62 overexpression induces neuron death. We found that stressors (proteasome inhibition and arsenic) increased p62 expression and that this shifted the nuclear:cytoplasmic TDP-43 ratio. Overall, our study suggests that environmental factors that increase p62 may thereby contribute to TDP-43 pathology in ALS and FTLD.

Identifiants

pubmed: 34075102
doi: 10.1038/s41598-021-90822-2
pii: 10.1038/s41598-021-90822-2
pmc: PMC8169680
doi:

Substances chimiques

DNA-Binding Proteins 0
Protein Aggregates 0
Sequestosome-1 Protein 0
Sqstm1 protein, mouse 0
TDP-43 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11474

Subventions

Organisme : Motor Neurone Disease Association
ID : LAYFIELD/APR16/845-791
Pays : United Kingdom

Références

Neurol Clin. 2015 Nov;33(4):877-88
pubmed: 26515627
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4696-4705
pubmed: 30770445
Nat Neurosci. 2019 Feb;22(2):180-190
pubmed: 30643298
Cell Rep. 2019 Apr 30;27(5):1409-1421.e6
pubmed: 31042469
Front Mol Neurosci. 2017 Aug 22;10:263
pubmed: 28878620
J Biol Chem. 2007 Apr 13;282(15):11068-77
pubmed: 17296612
Hum Mol Genet. 2018 Apr 15;27(8):1366-1381
pubmed: 29432563
EMBO J. 2016 Jan 18;35(2):121-42
pubmed: 26702100
Nucleic Acids Res. 2015 Oct 15;43(18):8990-9005
pubmed: 26261209
Ann Neurol. 2008 Jul;64(1):60-70
pubmed: 18546284
FASEB J. 2011 Jul;25(7):2344-53
pubmed: 21450909
Neurosci Lett. 2019 Sep 25;710:132933
pubmed: 28669745
Rev Neurol (Paris). 2017 May;173(5):273-279
pubmed: 28449882
Front Neurosci. 2018 May 15;12:326
pubmed: 29867335
J Bone Miner Res. 2006 Jul;21(7):1136-45
pubmed: 16813535
Neurochem Int. 2018 Jul;117:77-81
pubmed: 28527629
Neuroscience. 2015 Aug 6;300:94-103
pubmed: 25982564
Am J Hum Genet. 2016 Sep 1;99(3):735-743
pubmed: 27545679
Nat Commun. 2015 Jan 29;6:6183
pubmed: 25630387
Exp Cell Res. 2014 Jul 1;325(1):27-37
pubmed: 24486447
J Neurochem. 2011 Jan;116(2):248-59
pubmed: 21062285
J Neurochem. 2008 Jul;106(1):107-20
pubmed: 18346206
J Neurosci. 2007 Sep 26;27(39):10530-4
pubmed: 17898224
Neurosci Lett. 2003 May 15;342(1-2):41-4
pubmed: 12727313
Acta Neuropathol. 2004 Apr;107(4):359-64
pubmed: 14762676
J Proteome Res. 2009 Feb;8(2):770-81
pubmed: 19125615
PLoS One. 2010 Dec 31;5(12):e15878
pubmed: 21209826
Front Mol Neurosci. 2017 May 02;10:123
pubmed: 28512398
Alzheimers Dement. 2012 May;8(3):204-10
pubmed: 22465176
Neuropathology. 2010 Apr;30(2):170-81
pubmed: 20102522
Clin Epidemiol. 2015 Feb 12;7:181-93
pubmed: 25709501
J Bone Miner Res. 2005 Apr;20(4):619-24
pubmed: 15765181
PLoS One. 2012;7(8):e43120
pubmed: 22900096
J Cell Biol. 2005 Nov 21;171(4):603-14
pubmed: 16286508
J Biol Chem. 2008 Aug 15;283(33):22847-57
pubmed: 18524774
Front Cell Neurosci. 2018 Mar 22;12:79
pubmed: 29623031
J Biol Chem. 2001 Mar 16;276(11):7709-12
pubmed: 11244088
Trends Neurosci. 2020 May;43(5):274-284
pubmed: 32353332
J Neurosci Res. 2012 Oct;90(10):2034-42
pubmed: 22674379
Free Radic Biol Med. 2010 Mar 1;48(5):629-41
pubmed: 19969067
J Med Genet. 2017 Mar;54(3):145-154
pubmed: 28087719
Mol Brain. 2018 May 29;11(1):30
pubmed: 29843805
Exp Neurol. 2018 Jan;299(Pt A):15-25
pubmed: 28941811
J Neurol Sci. 2006 Nov 1;249(1):13-8
pubmed: 16820172
J Cereb Blood Flow Metab. 2014 Sep;34(9):1444-52
pubmed: 24917042
PLoS Genet. 2008 Sep 19;4(9):e1000193
pubmed: 18802454
Neuropathol Appl Neurobiol. 2002 Jun;28(3):228-37
pubmed: 12060347
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659

Auteurs

A D Foster (AD)

Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Harry Perkins Institute of Medical Research, University of Western Australia, Crawley, WA, Australia.

L L Flynn (LL)

Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Nedlands, WA, 6009, Australia.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch, WA, 6150, Australia.

C Cluning (C)

Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

F Cheng (F)

Department of Biomedical Sciences, Macquarie University, Sydney, Australia.

J M Davidson (JM)

Department of Biomedical Sciences, Macquarie University, Sydney, Australia.

A Lee (A)

Department of Biomedical Sciences, Macquarie University, Sydney, Australia.

N Polain (N)

Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Nedlands, WA, 6009, Australia.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch, WA, 6150, Australia.

R Mejzini (R)

Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Nedlands, WA, 6009, Australia.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch, WA, 6150, Australia.

N Farrawell (N)

School of Biological Sciences, University of Wollongong, Wollongong, 2522, Australia.

J J Yerbury (JJ)

School of Biological Sciences, University of Wollongong, Wollongong, 2522, Australia.

R Layfield (R)

School of Life Sciences, University of Nottingham, Nottingham, UK.

P A Akkari (PA)

Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Nedlands, WA, 6009, Australia.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch, WA, 6150, Australia.

S L Rea (SL)

Harry Perkins Institute of Medical Research, University of Western Australia, Crawley, WA, Australia. sarah.rea@murdoch.edu.au.
Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Nedlands, WA, 6009, Australia. sarah.rea@murdoch.edu.au.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch, WA, 6150, Australia. sarah.rea@murdoch.edu.au.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH